Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 13,191

Document Document Title
WO/2018/130282A1
The present invention relates to (guanidyl)x-oligosaccharidic compounds having a star-like structure having the capacity of carrying and delivering drugs or biological molecules such as oligonucleotides, polypetides and proteins across b...  
WO/2018/124696A1
The present invention relates to a novel caffeic acid compound separated from a Stauntonia hexaphylla leaf, and a pharmaceutical or food composition, for promoting bone formation or cartilage formation or for preventing, remedying or tre...  
WO/2018/124143A1
The purpose of the present invention is to determine the structure of a novel steviol glycoside that is detected in breeds containing an abundance of Reb.C (also called dulcoside B) and that affects the quality of taste in a small amount...  
WO/2018/124139A1
Provided are: a compound that induces a new type of stereoselective reaction that exhibits stereoselectivity during carbohydrate chain synthesis and produces acetal compounds; a production method for an acetal compound (e.g. a compound h...  
WO/2018/113285A1
Disclosed is a method for preparing sodium aescinate, relating to the technical field of plant extraction. The method comprises: semen aesculi is taken and subjected to alcohol extraction, the resulting extracting solution is subjected t...  
WO/2018/114933A1
The invention relates to novel glycosidase substrates of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R'9, V, X, Y and Z are as defined in claim 1, and a method for detecting the presence of a catalytically active glycosidase...  
WO/2018/112189A1
Methods of preparing novel steviol glycosides are described herein. The methods utilize biocatalysts for converting a starting steviol glycoside to a target steviol glycoside. Compositions and consumables comprising said novel steviol gl...  
WO/2018/109348A1
The present invention relates to a novel method for preparing surfactant compositions made from alkyl-L-iduronamides, alkyl-L-rhamnosides and alkyl-D-glucuronamides, the compositions obtained by said method and the uses thereof.  
WO/2018/102447A2
The invention relates to a process for producing food ingredients from Stevia rebaudiana plant and their use in food products, beverages and other consumables. Obtained compositions are useful as flavors, sweeteners, antioxidants, and ot...  
WO/2018/101434A1
The present invention addresses the problem of providing a glycosylated chlorin e6 derivative which has excellent tumor cell-killing properties (phototoxic property) and growth-inhibiting effect on tumor tissues and which is used for pho...  
WO/2018/100560A1
The present invention concerns Au and Cu-based mononuclear coordination compounds, drug formulations thereof, the relating synthesis and encapsulation method in macromolecules or supramolecular aggregates or nanostructures, as well as th...  
WO/2018/100561A1
The present invention relates to mononuclear coordination compounds of Au and Cu, pharmaceutical formulations based thereof, the relative method of synthesis and encapsulation of the compounds in macromolecules, supramolecular aggregates...  
WO/2018/100562A1
The present invention relates to mononuclear and dinuclear coordination compounds of Ru and Ga, pharmaceutical formulations based thereof, the relative method of synthesis and encapsulation of the compounds in macromolecules, supramolecu...  
WO/2018/098342A1
The present invention provides N-acetyl derivatives of sialic acids, including N-acetyl derivatives of Neu5Ac and Neu5Gc. Methods for preparing related precursors and a variety of sialosides are also disclosed.  
WO/2018/095975A1
The invention relates to the use of a triacylated mannosylerythritol lipid as a corrosion inhibitor, to compositions comprising a triacylated mannosylerythritol lipid, and to methods implementing a triacylated mannosylerythritol lipid.  
WO/2018/097239A1
The present invention addresses the problem of providing a clearing agent which is capable of, after administering a fusant of a streptavidin mutant with a molecular probe, preventing the localization of the fusant at a target site such ...  
WO/2018/089348A1
This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containi...  
WO/2018/083490A2
There is provided a molecule comprising a chain of seven or more contiguous units of 4,6-dideoxy-4-acylamido-α-pyranose, each pair of units joined by a C1-C2 or a C1-C3 link, the chain having a terminal end and a reducing end, wherein t...  
WO/2018/020326A3
Method for isolating monosialotetrahexosylganglioside (GMl) involves preparing porcine brain extract, adding sodium hydroxide, separating, conducting adsorption and desorption of extract, stirring, transferring mixture, adding hydrochlor...  
WO/2017/168200A3
A method of obtaining of sodium monosialganglioside and injectable preparation based on it is provided. The method consists in that the porcine brains are extracted with a mixture of trichloromethane, methyl alcohol, adsorption on the ma...  
WO/2018/075874A1
Novel diterpene glycosides isolated from Stevia are provided herein. Compositions and consumables comprising the novel diterpene glycosides are also provided herein. Methods of enhancing the sweetness and/or flavor of consumables using t...  
WO/2018/068090A1
The present invention relates generally to the field of glycanics and its application to the generation of glycoconjugates for therapeutic use. The present invention also relates to process for the preparation of glycoconjugates.  
WO/2018/070546A1
[Problem] To provide a novel hydrogelator which can be produced by a simple method and contains a monourea compound having a sugar structure. [Solution] This hydrogelator comprises a compound represented by formula (1) below (in the form...  
WO/2018/067683A1
Novel diterpene glycosides containing ent-atisene cores are provided herein. Compositions and consumables comprising the novel diterpene glycosides are also provided herein. Methods of enhancing the sweetness and/or flavor of consumables...  
WO/2018/067805A1
Disclosed are solid state forms of Sotagliflozin, processes for preparation thereof, and pharmaceutical compositions thereof.  
WO/2018/068010A1
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, highly potent multimeric ...  
WO/2018/067900A1
Provided herein are solid phase methods for the synthesis of conjugated oligomeric compounds and intermediates used in such methods. In particular, the solid phase methods provide for addition of a phosphoramidite functionalized conjugat...  
WO/2018/053202A1
The disclosure relates to the field of specialty chemicals. In particular, the disclosure provides novel 1,3-fatty-diol compounds of formulae (II) and (IV) and derivatives thereof, in partiuclar gycosides thereof, which are usefule.g.Jn ...  
WO/2018/050099A1
Provided is a panaxdiol-type ginsenoside derivative having a structure as shown in formula I or formula II. Also provided is the use thereof in the preparation of a drug for preventing and treating atherosclerosis. The panaxdiol-type gin...  
WO/2018/031585A1
The invention describes the extraction method to obtain the highest amount of resveratrol from wasted biomass produced by grapes processing. Resveratrol, which is found rich in the grapes, especially in grape skin and seed, is one of the...  
WO/2018/029272A1
A method for purifying rebaudioside M, which method comprises: (a) providing a solution comprising rebaudioside M at a concentration of at least about 10g/L and at a purity of at least about 10% by weight on a dry basis; and (b) crystall...  
WO/2018/030602A1
The present invention relates to: a novelly developed butane-tetraol-based amphipathic compound; a preparation method therefor; and a method for extracting, solubilizing, stabilizing, crystallizing, or analyzing membrane proteins by usin...  
WO/2018/029274A1
A method for purifying rebaudioside A, which method comprises: (a) providing a solution comprising rebaudioside A; (b) concentrating the said solution; and (c) crystallizing from the solution a high purity composition comprising rebaudio...  
WO/2018/026087A2
Compounds of chemical formula 1 or pharmaceutically acceptable salts thereof according to the present invention are sugar-added enclomiphene derivatives that improve bioavailability while maintaining antagonistic activity to estrogen rec...  
WO/2018/021527A1
The present invention addresses the problem of providing a method for supplying or maintaining type-17 collagen in a living body. The problem addressed by the present invention is solved by providing a composition having as an active ing...  
WO/2018/020046A1
The present invention provides a stable synthetic saccharide of Hib polyribosylribitol- phosphate (PRP) derivative and conjugate thereof. Said saccharide, said conjugate and pharmaceutical compositions thereof are hydrolysis-resistant, l...  
WO/2018/014866A1
Disclosed are a crystal form of a dapagliflozin intermediate and a preparation method therefor, and specifically disclosed are a crystal form of the dapagliflozin intermediate (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2-eth ...  
WO/2018/014111A1
There is provided methods, compositions and treatment regimens for treating cancer, or for inhibiting metastasis/recurrence of cancer in a patient using 1) a primary cancer treatment such as chemotherapy, and 2) within 12 to 120 hours po...  
WO/2018/012669A1
The present invention relates to a mesitylene-cored amphiphile, a method of preparing the same and a method of extraction, solubilization, stabilization, crystallization or analysis of a membrane protein using the same. When a mesitylene...  
WO/2018/007495A1
The present invention relates to compounds of formula (I) and compositions comprising them for use in enhancing umami taste and/ or saltiness of a food product.  
WO/2018/007496A1
The present invention relates to compounds and compositions for use in enhancing flavor and/or saltiness of a food product. Particularly, the present invention relates to compounds of the general formula I) and compositions comprising them.  
WO/2018/005324A1
Disclosed herein are artificial Invaplexes comprising deacylated lipopolysaccharides and methods of making and using thereof.  
WO/2018/003652A1
A compound used in the conventional enzymatic reactions and mass spectrometry methods needs to be altered with respect to the structure thereof as a substrate compound, such as the length of an alkyl chain contained therein, depending on...  
WO/2017/218888A1
Compositions and uses for steviol glycoside compounds having four glucopyranose residues attached via the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose residues attached via the number 19 c...  
WO/2017/207754A1
The invention describes novel conjugates of formula (I) of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein allowing a reversible release of the pharmaceutical agent depending on the glucose concentration.  
WO/2017/202351A1
The present invention relates to a new crystal form of a sodium-glucose co-transporter inhibitor medicine (Sotagliflozin) and a preparation method and use thereof. In addition, the present invention relates to a pharmaceutical compositio...  
WO/2017/205269A1
Compounds of Formula (I), compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, haloalkyl ...  
WO/2016/196927A8
Methods of using and pharmaceutical compositions comprising (2R,3S,4R,5R,6S)-5- amino-6-(((lR,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5 -dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl) oxy)-2-hydroxycyclohexyl)oxy)-2- (h...  
WO/2017/174748A3
Surfactants based on a newly discovered class of compounds include a hydrophobic lipid oligomer covalently linked to a peptide or peptide-like chain and a carbohydrate moiety, and a serine- leucinol dipeptide linked to the lipid oligomer...  
WO/2017/199028A1
A method of preparing an active agent or a salt thereof from a prodrug first compound (1) comprising a propargyl group connected to an oxygen that is directly or indirectly connected to the active agent is provided, wherein the bond betw...  

Matches 151 - 200 out of 13,191